North America Preventive Vaccines Market
North America preventive vaccines market is expected to grow by 10.42% annually in the forecast p ... Read More
1 Introduction 9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 23 2.1.2 Impact of COVID-19 on the Market 25 2.2 Major Growth Drivers 27 2.3 Market Restraints and Challenges 30 2.4 Emerging Opportunities and Market Trends 33 2.5 Porter’s Fiver Forces Analysis 37 3 Segmentation of Global Market by Vaccine Type 41 3.1 Market Overview by Vaccine Type 41 3.2 Live/Attenuated Vaccines 43 3.3 Inactivated Vaccines 44 3.4 Subunit Vaccines 45 3.5 Toxoid Vaccines 46 3.6 Conjugate Vaccines 47 3.7 Recombinant Vector Vaccines 48 3.8 Other Vaccines 49 4 Segmentation of Global Market by Disease 50 4.1 Market Overview by Disease 50 4.2 Vaccines for Pneumococcal Disease 52 4.3 Vaccines for Poliovirus 53 4.4 Vaccines for Hepatitis 54 4.5 Vaccines for Influenza 55 4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 56 4.7 Vaccines for Varicella 57 4.8 Vaccines for Human Papilloma Virus 58 4.9 Vaccines for COVID-19 59 4.10 Vaccines for Other Diseases 62 5 Segmentation of Global Market by Administration 63 5.1 Market Overview by Administration 63 5.2 Intramuscular Route 65 5.3 Subcutaneous Route 66 5.4 Oral Route 67 5.5 Intravenous Injection 68 5.6 Other Administration Routes 69 6 Segmentation of Global Market by Patient 70 6.1 Market Overview by Patient 70 6.2 Pediatric Vaccines 72 6.3 Adult Vaccines 74 7 Segmentation of Global Market by Region 76 7.1 Geographic Market Overview 2020-2026 76 7.2 North America Market 2020-2026 by Country 80 7.2.1 Overview of North America Market 80 7.2.2 U.S. 83 7.2.3 Canada 88 7.2.4 Mexico 91 7.3 European Market 2020-2026 by Country 94 7.3.1 Overview of European Market 94 7.3.2 UK 97 7.3.3 France 100 7.3.4 Germany 103 7.3.5 Spain 106 7.3.6 Italy 109 7.3.7 Russia 112 7.3.8 Rest of European Market 115 7.4 Asia-Pacific Market 2020-2026 by Country 117 7.4.1 Overview of Asia-Pacific Market 117 7.4.2 China 120 7.4.3 Japan 123 7.4.4 India 127 7.4.5 Australia 130 7.4.6 South Korea 133 7.4.7 Rest of APAC Region 136 7.5 South America Market 2020-2026 by Country 138 7.5.1 Argentina 141 7.5.2 Brazil 144 7.5.3 Colombia 147 7.5.4 Rest of South America Market 150 7.6 MEA Market 2020-2026 by Country 151 7.6.1 UAE 154 7.6.2 Saudi Arabia 157 7.6.3 Egypt 160 7.6.4 Other National Markets 163 8 Competitive Landscape 164 8.1 Overview of Key Vendors 164 8.2 New Product Launch, Partnership, Investment, and M&A 167 8.3 Company Profiles 168 AstraZeneca plc 168 Bavarian Nordic A/S 171 China National Biotec Group Company Ltd. 174 CSL Ltd. 176 Daiichi Sankyo Co. Ltd 178 Emergent BioSolutions Inc. 180 GlaxoSmithKline plc 182 Johnson & Johnson 186 Merck & Co. 188 Moderna Inc. 190 Novavax, Inc. 191 Pfizer Inc. 193 Sanofi SA 197 Takeda Pharmaceutical Co. Ltd. 199 9 Investing in Global Market: Risk Assessment and Management 201 9.1 Risk Evaluation of Global Market 201 9.2 Critical Success Factors (CSFs) 204 Related Reports and Products 207
Table 1. Snapshot of Global Preventive Vaccines Market in Balanced Perspective, 2020-2026 19 Table 2. Growth Rate of World GDP, 2020-2022 24 Table 3. Main Product Trends and Market Opportunities in Global Preventive Vaccines Market 33 Table 4. Global Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 41 Table 5. Global Preventive Vaccines Market by Disease, 2016-2026, $ mn 50 Table 6. COVID-19 Vaccines Authorized for Emergency Use or Approved for Full Use, as of April 2021 60 Table 7. Global Preventive Vaccines Market by Administration, 2016-2026, $ mn 63 Table 8. Global Preventive Vaccines Market by Patient, 2016-2026, $ mn 70 Table 9. Global Preventive Vaccines Market: Pediatric Vaccines by Disease, 2016-2026, $ mn 73 Table 10. Global Preventive Vaccines Market: Adult Vaccines by Disease, 2016-2026, $ mn 75 Table 11. Global Preventive Vaccines Market by Region, 2016-2026, $ mn 77 Table 12. Leading National Preventive Vaccines Market, 2020 and 2026, $ mn 79 Table 13. North America Preventive Vaccines Market by Country, 2016-2026, $ mn 82 Table 14. U.S. Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 85 Table 15. U.S. Preventive Vaccines Market by Disease, 2016-2026, $ mn 85 Table 16. U.S. Preventive Vaccines Market by Administration, 2016-2026, $ mn 86 Table 17. Canada Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 89 Table 18. Canada Preventive Vaccines Market by Disease, 2016-2026, $ mn 89 Table 19. Canada Preventive Vaccines Market by Administration, 2016-2026, $ mn 90 Table 20. Mexico Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 92 Table 21. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn 92 Table 22. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn 93 Table 23. Europe Preventive Vaccines Market by Country, 2016-2026, $ mn 96 Table 24. UK Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 98 Table 25. UK Preventive Vaccines Market by Disease, 2016-2026, $ mn 98 Table 26. UK Preventive Vaccines Market by Administration, 2016-2026, $ mn 99 Table 27. France Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 101 Table 28. France Preventive Vaccines Market by Disease, 2016-2026, $ mn 101 Table 29. France Preventive Vaccines Market by Administration, 2016-2026, $ mn 102 Table 30. Germany Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 104 Table 31. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn 104 Table 32. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn 105 Table 33. Spain Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 107 Table 34. Spain Preventive Vaccines Market by Disease, 2016-2026, $ mn 107 Table 35. Spain Preventive Vaccines Market by Administration, 2016-2026, $ mn 108 Table 36. Italy Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 110 Table 37. Italy Preventive Vaccines Market by Disease, 2016-2026, $ mn 110 Table 38. Italy Preventive Vaccines Market by Administration, 2016-2026, $ mn 111 Table 39. Russia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 113 Table 40. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn 113 Table 41. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn 114 Table 42. Preventive Vaccines Market in Rest of Europe by Country, 2016-2026, $ mn 116 Table 43. APAC Preventive Vaccines Market by Country, 2016-2026, $ mn 119 Table 44. China Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 121 Table 45. China Preventive Vaccines Market by Disease, 2016-2026, $ mn 121 Table 46. China Preventive Vaccines Market by Administration, 2016-2026, $ mn 122 Table 47. Japan Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 125 Table 48. Japan Preventive Vaccines Market by Disease, 2016-2026, $ mn 125 Table 49. Japan Preventive Vaccines Market by Administration, 2016-2026, $ mn 126 Table 50. India Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 128 Table 51. India Preventive Vaccines Market by Disease, 2016-2026, $ mn 128 Table 52. India Preventive Vaccines Market by C Administration, 2016-2026, $ mn 129 Table 53. Australia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 131 Table 54. Australia Preventive Vaccines Market by Disease, 2016-2026, $ mn 131 Table 55. Australia Preventive Vaccines Market by Administration, 2016-2026, $ mn 132 Table 56. South Korea Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 134 Table 57. South Korea Preventive Vaccines Market by Disease, 2016-2026, $ mn 134 Table 58. South Korea Preventive Vaccines Market by Administration, 2016-2026, $ mn 135 Table 59. Preventive Vaccines Market in Rest of APAC by Country, 2016-2026, $ mn 137 Table 60. South America Preventive Vaccines Market by Country, 2016-2026, $ mn 140 Table 61. Argentina Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 142 Table 62. Argentina Preventive Vaccines Market by Disease, 2016-2026, $ mn 142 Table 63. Argentina Preventive Vaccines Market by Administration, 2016-2026, $ mn 143 Table 64. Brazil Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 145 Table 65. Brazil Preventive Vaccines Market by Disease, 2016-2026, $ mn 145 Table 66. Brazil Preventive Vaccines Market by Administration, 2016-2026, $ mn 146 Table 67. Colombia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 148 Table 68. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn 148 Table 69. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn 149 Table 70. MEA Preventive Vaccines Market by Country, 2016-2026, $ mn 153 Table 71. UAE Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 155 Table 72. UAE Preventive Vaccines Market by Disease, 2016-2026, $ mn 155 Table 73. UAE Preventive Vaccines Market by Administration, 2016-2026, $ mn 156 Table 74. Saudi Arabia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 158 Table 75. Saudi Arabia Preventive Vaccines Market by Disease, 2016-2026, $ mn 158 Table 76. Saudi Arabia Preventive Vaccines Market by Administration, 2016-2026, $ mn 159 Table 77. Egypt Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn 161 Table 78. Egypt Preventive Vaccines Market by Disease, 2016-2026, $ mn 161 Table 79. Egypt Preventive Vaccines Market by Administration, 2016-2026, $ mn 162 Table 80. AstraZeneca plc: Company Snapshot 168 Table 81. AstraZeneca plc: Revenue, 2018-2020, $ bn 169 Table 82. Bavarian Nordic A/S: Company Snapshot 171 Table 83. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020 172 Table 84. China National Biotec Group Company Ltd.: Company Snapshot 174 Table 85. CSL Ltd.: Company Snapshot 176 Table 86. Daiichi Sankyo Co. Ltd.: Company Snapshot 178 Table 87. Emergent BioSolutions Inc.: Company Snapshot 180 Table 88. GlaxoSmithKline: Company Snapshot 182 Table 89. GlaxoSmithKline: Business Segmentation 183 Table 90. GlaxoSmithKline: Product Portfolio 184 Table 91. GlaxoSmithKline: Revenue, 2018-2020, $ bn 185 Table 92. GlaxoSmithKline: Recent Developments 185 Table 93. Johnson & Johnson: Company Snapshot 186 Table 94. Johnson & Johnson: Business Segments 187 Table 95. Merck & Co., Inc.: Company Snapshot 188 Table 96. Merck & Co., Inc.: Business Segmentation 188 Table 97. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 189 Table 98. Moderna Inc.: Company Snapshot 190 Table 99. Novavax, Inc.: Company Snapshot 191 Table 100. Pfizer Inc.: Company Snapshot 193 Table 101. Pfizer Inc.: Business Segmentation 194 Table 102. Pfizer Inc.: Product Portfolio 195 Table 103. Pfizer Inc.: Revenue, 2018-2020, $ bn 196 Table 104. Pfizer Inc.: Recent Developments 196 Table 105. Sanofi: Company Snapshot 197 Table 106. Sanofi: Business Segmentation 197 Table 107. Sanofi: Revenue, 2018-2020, $ bn 198 Table 108. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 199 Table 109. Risk Evaluation for Investing in Global Market, 2020-2026 202 Table 110. Critical Success Factors and Key Takeaways 205
Figure 1. Research Method Flow Chart 13 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2026 18 Figure 4. Global Preventive Vaccines Market, 2016-2026, $ mn 21 Figure 5. Development Stages of Preventive Vaccines 22 Figure 6. Impact of COVID-19 on Business 25 Figure 7. Primary Drivers and Impact Factors of Global Preventive Vaccines Market 27 Figure 8. Primary Restraints and Impact Factors of Global Preventive Vaccines Market 30 Figure 9. Investment Opportunity Analysis 34 Figure 10. Porter’s Fiver Forces Analysis of Global Preventive Vaccines Market 37 Figure 11. Breakdown of Global Preventive Vaccines Market by Vaccine Type, 2020-2026, % of Revenue 42 Figure 12. Contribution to Global 2021-2026 Cumulative Revenue by Vaccine Type, Value ($ mn) and Share (%) 42 Figure 13. Global Preventive Vaccines Market: Live/Attenuated Vaccines, 2016-2026, $ mn 43 Figure 14. Global Preventive Vaccines Market: Inactivated Vaccines, 2016-2026, $ mn 44 Figure 15. Global Preventive Vaccines Market: Subunit Vaccines, 2016-2026, $ mn 45 Figure 16. Global Preventive Vaccines Market: Toxoid Vaccines, 2016-2026, $ mn 46 Figure 17. Global Preventive Vaccines Market: Conjugate Vaccines, 2016-2026, $ mn 47 Figure 18. Global Preventive Vaccines Market: Recombinant Vector Vaccines, 2016-2026, $ mn 48 Figure 19. Global Preventive Vaccines Market: Other Vaccines, 2016-2026, $ mn 49 Figure 20. Breakdown of Global Preventive Vaccines Market by Disease, 2020-2026, % of Revenue 51 Figure 21. Contribution to Global 2021-2026 Cumulative Revenue by Disease, Value ($ mn) and Share (%) 51 Figure 22. Global Preventive Vaccines Market: Vaccines for Pneumococcal Disease, 2016-2026, $ mn 52 Figure 23. Global Preventive Vaccines Market: Vaccines for Poliovirus, 2016-2026, $ mn 53 Figure 24. Global Preventive Vaccines Market: Vaccines for Hepatitis, 2016-2026, $ mn 54 Figure 25. Global Preventive Vaccines Market: Vaccines for Influenza, 2016-2026, $ mn 55 Figure 26. Global Preventive Vaccines Market: Vaccines for Measles, Mumps, and Rubella (MMR), 2016-2026, $ mn 56 Figure 27. Global Preventive Vaccines Market: Vaccines for Varicella, 2016-2026, $ mn 57 Figure 28. Global Preventive Vaccines Market: Vaccines for Human Papilloma Virus, 2016-2026, $ mn 58 Figure 29. Global Preventive Vaccines Market: Vaccines for COVID-19, 2016-2026, $ mn 59 Figure 30. Global Preventive Vaccines Market: Vaccines for Other Diseases, 2016-2026, $ mn 62 Figure 31. Breakdown of Global Preventive Vaccines Market by Administration, 2020-2026, % of Revenue 64 Figure 32. Contribution to Global 2021-2026 Cumulative Revenue by Administration, Value ($ mn) and Share (%) 64 Figure 33. Global Preventive Vaccines Market: Intramuscular Route, 2016-2026, $ mn 65 Figure 34. Global Preventive Vaccines Market: Subcutaneous Route, 2016-2026, $ mn 66 Figure 35. Global Preventive Vaccines Market: Oral Route, 2016-2026, $ mn 67 Figure 36. Global Preventive Vaccines Market: Intravenous Injection, 2016-2026, $ mn 68 Figure 37. Global Preventive Vaccines Market: Other Administration Routes, 2016-2026, $ mn 69 Figure 38. Breakdown of Global Preventive Vaccines Market by Patient, 2020-2026, % of Revenue 70 Figure 39. Contribution to Global 2021-2026 Cumulative Revenue by Patient, Value ($ mn) and Share (%) 71 Figure 40. Global Preventive Vaccines Market: Pediatric Vaccines, 2016-2026, $ mn 72 Figure 41. Global Preventive Vaccines Market: Adult Vaccines, 2016-2026, $ mn 74 Figure 42. Global Market Snapshot by Region 76 Figure 43. Geographic Spread of Worldwide Preventive Vaccines Market, 2020-2026, % of Revenue 77 Figure 44. Contribution to Global 2021-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%) 78 Figure 45. North American Preventive Vaccines Market, 2016-2026, $ mn 81 Figure 46. Breakdown of North America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue 81 Figure 47. Contribution to North America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 82 Figure 48. U.S. Preventive Vaccines Market, 2016-2026, $ mn 84 Figure 49. Canada Preventive Vaccines Market, 2016-2026, $ mn 88 Figure 50. Preventive Vaccines Market in Mexico, 2016-2026, $ mn 91 Figure 51. European Preventive Vaccines Market, 2016-2026, $ mn 95 Figure 52. Breakdown of European Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue 95 Figure 53. Contribution to Europe 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 96 Figure 54. Preventive Vaccines Market in UK, 2016-2026, $ mn 97 Figure 55. Preventive Vaccines Market in France, 2016-2026, $ mn 100 Figure 56. Preventive Vaccines Market in Germany, 2016-2026, $ mn 103 Figure 57. Preventive Vaccines Market in Spain, 2016-2026, $ mn 106 Figure 58. Preventive Vaccines Market in Italy, 2016-2026, $ mn 109 Figure 59. Preventive Vaccines Market in Russia, 2016-2026, $ mn 112 Figure 60. Preventive Vaccines Market in Rest of Europe, 2016-2026, $ mn 115 Figure 61. Asia-Pacific Preventive Vaccines Market, 2016-2026, $ mn 118 Figure 62. Breakdown of APAC Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue 118 Figure 63. Contribution to APAC 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 119 Figure 64. Preventive Vaccines Market in China, 2016-2026, $ mn 120 Figure 65. Preventive Vaccines Market in Japan, 2016-2026, $ mn 124 Figure 66. Preventive Vaccines Market in India, 2016-2026, $ mn 127 Figure 67. Preventive Vaccines Market in Australia, 2016-2026, $ mn 130 Figure 68. Preventive Vaccines Market in South Korea, 2016-2026, $ mn 133 Figure 69. Preventive Vaccines Market in Rest of APAC, 2016-2026, $ mn 136 Figure 70. South America Preventive Vaccines Market, 2016-2026, $ mn 139 Figure 71. Breakdown of South America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue 139 Figure 72. Contribution to South America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 140 Figure 73. Preventive Vaccines Market in Argentina, 2016-2026, $ mn 141 Figure 74. Preventive Vaccines Market in Brazil, 2016-2026, $ mn 144 Figure 75. Preventive Vaccines Market in Colombia, 2016-2026, $ mn 147 Figure 76. Preventive Vaccines Market in Rest of South America, 2016-2026, $ mn 150 Figure 77. Preventive Vaccines Market in Middle East and Africa (MEA), 2016-2026, $ mn 152 Figure 78. Breakdown of MEA Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue 152 Figure 79. Contribution to MEA 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 153 Figure 80. Preventive Vaccines Market in UAE, 2016-2026, $ mn 154 Figure 81. Preventive Vaccines Market in Saudi Arabia, 2016-2026, $ mn 157 Figure 82. Preventive Vaccines Market in Egypt, 2016-2026, $ mn 160 Figure 83. Growth Stage of Global Preventive Vaccines Industry over the Forecast Period 164 Figure 84. Top Products of AstraZeneca Based on Revenue from 2016 to 2019 (in million U.S. dollars) 169
Key Players (this may not be a complete list and extra companies can be added upon request): AstraZeneca plc Bavarian Nordic A/S China National Biotec Group Company Ltd. CSL Ltd. Daiichi Sankyo Co. Ltd Emergent BioSolutions Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co. Moderna Inc. Novavax, Inc. Pfizer Inc. Sanofi SA Takeda Pharmaceutical Co. Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
North America preventive vaccines market is expected to grow by 10.42% annually in the forecast p ... Read More
Europe preventive vaccines market accounted for $10.64 billion in 2020 and will grow by 10.72% an ... Read More
Asia Pacific preventive vaccines market will grow by 13.32% annually with a total addressable mar ... Read More
Global virus filtration market will reach $6,275.3 million by 2026, growing by 12.26% annually ov ... Read More